Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells

International Journal of Cancer

Volumn 97, Issue 2, 2002, Pages 157-162

  Monvoisin, Arnaud ^a   Bisson, Christèle ^a   Si Tayeb, Karim ^a   Balabaud, Charles ^a   Desmoulière, Alexis ^a   Rosenbaum, Jean ^a  

^a INSERM   (France)

Author keywords

Liver; Marimastat; Myofibroblast; Stromelysin; TIMP

Indexed keywords

COLLAGENASE 3; GELATINASE A; MARIMASTAT; SCATTER FACTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL INVASION; CELL STRAIN HEPG2; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; COLLAGEN; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME INHIBITORS; HEPATOCYTE GROWTH FACTOR; HUMANS; HYDROXAMIC ACIDS; LAMININ; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED;

EID: 0037050023     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1595     Document Type: Article

References (45)

1. Extracellular matrix 6: Role of matrix metalloproteinase in tumor invasion and metastasis
2. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization
3. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)
4. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate
5. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties
6. Direct activation of human neutrophil procollagenase by recombinant stromelysin
7. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
8. Mechanisms for pro matrix metalloproteinase activation
9. Stimulation of in vitro human skin collagenase expression by platelet- derived growth factor
10. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
11. Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene
12. Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression
13. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production
14. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumors
15. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas
16. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease
17. Stromelysin/transin and tumor progression
18. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
19. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1
20. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development
21. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties
22. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor
23. Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase
24. Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma
25. Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: Evidence for mediation by endogenous platelet-derived growth factor
26. Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver
27. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors
28. A high throughput fluorogenic substrate for stromelysin (MMP-3)
29. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction
30. Hepatocyte growth factor secreted by human liver myofibroblasts increases invasiveness of hepatocellular carcinoma cells
31. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
32. Cell surface-bound collagenase-1 and focal substrate degradation stimulate the rear release of motile vascular smooth muscle cells
33. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
34. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
35. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor-and scatter factor-stimulated invasion of carcinoma cells
36. Invasiveness of hepatocellular carcinoma cell lines: Contribution of membrane-type 1 matrix metalloproteinase
37. In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis
38. Expression pattern of matrix metalloproteinases in human liver
39. Differential distribution of five members of the matrix metalloproteinase family and one inhibitor (TIMP-1) in human liver and skin
40. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas
41. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors
42. The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate
43. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma
44. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor and tissue-type PA messenger RNAs in human hepatocellular carcinoma
45. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3)